Complement In Hematologic Disorders
Complement in Hematologic Disorders is a theoretical framework within immunopharmacology that elucidates the dysregulation and pathogenic role of the complement system in the etiology and progression of blood-related diseases.
543
Publications
30.6K
Citations
2.4K
Authors
774
Institutions
Publications per year
2017–2026
91
543
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text
Atypical hemolytic uremic syndrome
Chantal Loirat, Véronique Frémeaux‐Bacchi · Orphanet Journal of Rare Diseases · 2011 · 664 citations · Full text
Medicine, Hematology, Nephrology +17
1–5 of 543
2.4K
21
h-index
16
h-index
10
h-index
Centro de Investigaciones Biológicas Margarita Salas, Spain
9 publications · 793 citations
9
h-index
9
h-index
1–5 of 2.4K
774
Duke Medical Center
Durham, United States
23 h-index
72 publications
4.8K citations
Inserm
Paris, France
17 h-index
110 publications
11.4K citations
Assistance Publique – Hôpitaux de Paris
Paris, France
16 h-index
52 publications
7.3K citations
Duke University Hospital
Durham, United States
16 h-index
40 publications
3K citations
Hôpital Européen
Marseille, France
15 h-index
32 publications
4K citations
Hôpital Européen Georges-Pompidou
Paris, France
15 h-index
34 publications
4.2K citations
Université Paris Cité
Paris, France
14 h-index
67 publications
11K citations
Duke University
Durham, United States
13 h-index
33 publications
2.3K citations
1–8 of 774
51 publications · 3.6K citations
32
h-index
JCI · 31 publications · 3.9K citations
27
h-index
Repository · 59 publications · 2.1K citations
27
h-index
BJH · 35 publications · 1.4K citations
23
h-index
24 publications · 698 citations
17
h-index
1–5